Source: WRAL TechWire Durham-based Novan goes public at $11 a share - and its stock shows plenty of "pop," surging more than 70 percent just ahead of the market close Wednesday. Novan priced its IPO at about $44 million, down from an earlier target of $60 million. But when trading…...
Allergan to Buy Vitae Pharmaceuticals for $639 Million
Source: Allergan PLC agreed to acquire clinical-stage biotechnology company Vitae Pharmaceuticals Inc. for $639 million, more than double its market value, in a move aimed at strengthening the drugmaker’s skin-care pipeline. The price values Vitae at $21 a share, compared with the company’s closing price of $8.10 on Tuesday. Vitae…...
Horizon Pharma to buy Raptor Pharma for $800 mln
Source: Horizon Pharma Plc (HZNP.O) said it would buy Raptor Pharmaceutical Corp (RPTP.O) for nearly $800 million to bolster its portfolio of drugs to treat rare diseases and reduce its dependence on the primary care market. The deal will give Horizon drugs used to treat diseases including rare metabolic disorders…...